XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS' DEFICIT (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Share-based Compensation Arrangements by Share-based Payment Award
Stock-based compensation expense for the three months ended March 31, 2024 and 2023, is included in the Company’s Consolidated Statements of Operations as follows (in thousands):

Three Months Ended March 31,
20242023
Cost of revenue$959 $597 
Research and development204 442 
Sales and marketing421 505 
General and administrative
(2,644)10,729 
Total stock-based compensation expense1
$(1,060)$12,273 
1 Includes reversal of stock-based compensation expense due to $6.1 million in forfeitures incurred during the three months ended March 31, 2024. Stock-based compensation expense excluding the impact of these forfeitures would have been approximately $5.1 million.